The LRRC26 protein selectively alters the efficacy of BK channel activators

Molecular Pharmacology

Volumn 81, Issue 1, 2012, Pages 21-30

  Almassy, Janos ^a   Begenisich, Ted ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; CALCIUM; CARRIER PROTEIN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; LRRC26 PROTEIN; ROTTLERIN; UNCLASSIFIED DRUG;

ACINAR CELL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; HYPERPOLARIZATION; MOUSE; NONHUMAN; PAROTID GLAND; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STEADY STATE;

ACINAR CELLS; ANIMALS; BENZIMIDAZOLES; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MEMBRANE POTENTIALS; MICE; NEOPLASM PROTEINS; PAROTID GLAND; PATCH-CLAMP TECHNIQUES; PICROTOXIN; POTASSIUM CHANNELS;

EID: 84455162079     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.075234     Document Type: Article

References (40)

1. 2+ sensitivity is enhanced by its beta1 subunit. J Gen Physiol 126:393-412.
2. Brayden JE and Nelson MT (1992) Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 256:532-535.
3. Butler A, Tsunoda S, McCobb DP, Wei A, and Salkoff L (1993) mSlo, a complex mouse gene encoding "maxi" calcium-activated potassium channels. Science 261:221-224. (Pubitemid 23265401)
4. Diaz L, Meera P, Amigo J, Stefani E, Alvarez O, Toro L, and Latorre R (1998) Role of the S4 segment in a voltage-dependent calcium-sensitive potassium (hSlo) channel. J Biol Chem 273:32430-32436. (Pubitemid 28557615)
5. +channels. J Neurosci 17:4942-4955.
6. + conduction and selectivity. Science 280:69-77.
7. Egland KA, Liu XF, Squires S, Nagata S, Man YG, Bera TK, Onda M, Vincent JJ, Strausberg RL, Lee B, et al. (2006) High expression of a cytokeratin-associated protein in many cancers. Proc Natl Acad Sci USA 103:5929-5934.
8. Garcia ML, Giacobbe RA, Hensens OD, Kaczorowski GJ, Lee SH, McManus OB, and Zink DL (1995), inventors; Merck & Co., assignee. Biologically active compounds. U.S. patent 5,399,587. 1995 Mar 21.
9. Garcia ML, Goetz MA, Kaczorowski GJ, McManus OB, Monaghan RL, Strohl WR, and Tkacz JS (2007), inventors; Merck & Co., assignee. Maxi-K channel blockers, methods of use and process for making the same. U.S. patent 7,294,646. 2007 Nov 13.
10. Ca channels activating at resting potential without calcium in LNCaP prostate cancer cells. J Membr Biol 208:229-240.
11. Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, and Yates JR (2009) Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res 8:1304-1314.
12. Gribkoff VK, Starrett JE Jr, and Dworetzky SI (1997) The pharmacology and molecular biology of large-conductance calcium-activated (BK) potassium channels. Adv Pharmacol 37:319-348.
13. Gribkoff VK, Starrett JE Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, et al. (2001) Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med 7:471-477. (Pubitemid 32298551)
14. Horrigan FT and Aldrich RW (1999) Allosteric voltage gating of potassium channels II. Mslo channel gating charge movement in the absence of Ca2+. J Gen Physiol 114:305-336. (Pubitemid 29380156)
15. 2+ binding and channel opening in large conductance (BK) potassium channels. J Gen Physiol 120:267-305.
16. Horrigan FT, Cui J, and Aldrich RW (1999) Allosteric voltage gating of potassium channels I. Mslo ionic currents in the absence of Ca2+. J Gen Physiol 114:277-304. (Pubitemid 29380155)
17. Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, and Maylie J (1997) A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci USA 94:11651-11656. (Pubitemid 127650718)
18. Jensen BS, Teuber L, Strobaek D, Christophersen P, and Olesen SP (2003), inventors; NeuroSearch A/S, assignee. Use of ion channel modulation agents. U.S. patent 6,525,043. 2003 Feb 25.
19. Jiang Y, Lee A, Chen J, Cadene M, Chait BT, and MacKinnon R (2002) Crystal structure and mechanism of a calcium-gated potassium channel. Nature 417:515-522. (Pubitemid 34595912)
20. Latorre R, Oberhauser A, Labarca P, and Alvarez O (1989) Varieties of calciumactivated potassium channels. Annu Rev Physiol 51:385-399.
21. Long SB, Campbell EB, and Mackinnon R (2005) Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science 309:897-903. (Pubitemid 41099919)
22. Magleby KL (2003) Gating mechanism of BK (Slo1) channels: so near, yet so far. J Gen Physiol 121:81-96.
23. Marx SO and Zakharov SI (2006), inventors; Trustees of Columbia University in the City of New York, Marx SO, and Zakharov SI, assignees. Use of rottlerin and its derivatives as activators of BK channel for therapy of hypertension and related disorders. World patent WO2006060196. 2006 Jun 8.
24. Nardi A and Olesen SP (2008) BK channel modulators: a comprehensive overview. Curr Med Chem 15:1126-1146. (Pubitemid 352002981)
25. + channels in parotid acinar cells. Am J Physiol Cell Physiol 284:C535-C546.
26. Orio P and Latorre R (2005) Differential effects of beta 1 and beta 2 subunits on BK channel activity. J Gen Physiol 125:395-411.
27. Romanenko V, Nakamoto T, Srivastava A, Melvin JE, and Begenisich T (2006) Molecular identification and physiological roles of parotid acinar cell maxi-K channels. J Biol Chem 281:27964-27972.
28. + channels in mouse submandibular glands. J Physiol 581:801-817.
29. 2+- activated K channels in parotid acinar cells: The functional basis for the hyperpolarized activation of BK channels. Channels (Austin) 4:278-288.
30. 2+ suggest a two-tiered allosteric gating mechanism. J Gen Physiol 114:93-124.
31. + channels described by a two-tiered allosteric gating mechanism. J Gen Physiol 116:75-99.
32. Salkoff L, Butler A, Ferreira G, Santi C, and Wei A (2006) High-conductance potassium channels of the SLO family. Nat Rev Neurosci 7:921-931.
33. + channel (hslo). Proc Natl Acad Sci USA 94:5427-5431.
34. 2+. Neuropharmacology 35:903-914.
35. Teuber L, Christophersen P, Strobaek D, and Jensen BS (2003) inventors; Neurosearch A/S, assignee. Ion channel modulating agents comprising novel benzimidazolone derivatives. U.S. Patent 6,624,186. 23 Sep 2003.
36. Thompson J and Begenisich T (2006) Membrane-delimited inhibition of maxi-K channel activity by the intermediate conductance Ca2+-activated K channel. J Gen Physiol 127:159-169. (Pubitemid 43177138)
37. Cachannels at negative potentials in mammalian inner hair cells. J Physiol 569:137-151.
38. Wang B, Rothberg BS, and Brenner R (2006) Mechanism of beta4 subunit modulation of BK channels. J Gen Physiol 127:449-465.
39. Yan J and Aldrich RW (2010) LRRC26 auxiliary protein allows BK channel activation at resting voltage without calcium. Nature 466:513-516.
40. Zakharov SI, Morrow JP, Liu G, Yang L, and Marx SO (2005) Activation of the BK (SLO1) potassium channel by mallotoxin. J Biol Chem 280:30882-30887. (Pubitemid 41291819)